| Multiple early factors anticipate post-acute COVID-19 sequelae Y Su, D Yuan, DG Chen, RH Ng, K Wang, J Choi, S Li, S Hong, R Zhang, ... Cell 185 (5), 881-895. e20, 2022 | 837 | 2022 |
| Transcriptional downregulation of S1pr1 is required for the establishment of resident memory CD8+ T cells CN Skon, JY Lee, KG Anderson, D Masopust, KA Hogquist, SC Jameson Nature immunology 14 (12), 1285-1293, 2013 | 793 | 2013 |
| Intravascular staining for discrimination of vascular and tissue leukocytes KG Anderson, K Mayer-Barber, H Sung, L Beura, BR James, JJ Taylor, ... Nature protocols 9 (1), 209-222, 2014 | 736 | 2014 |
| Obstacles posed by the tumor microenvironment to T cell activity: a case for synergistic therapies KG Anderson, IM Stromnes, PD Greenberg Cancer cell 31 (3), 311-325, 2017 | 649 | 2017 |
| Cutting edge: intravascular staining redefines lung CD8 T cell responses KG Anderson, H Sung, CN Skon, L Lefrancois, A Deisinger, V Vezys, ... The Journal of Immunology 189 (6), 2702-2706, 2012 | 344 | 2012 |
| Accumulation of long-chain fatty acids in the tumor microenvironment drives dysfunction in intrapancreatic CD8+ T cells T Manzo, BM Prentice, KG Anderson, A Raman, A Schalck, GS Codreanu, ... Journal of Experimental Medicine 217 (8), 2020 | 183 | 2020 |
| Considerations for treatment duration in responders to immune checkpoint inhibitors TU Marron, AE Ryan, SM Reddy, S Kaczanowska, RH Younis, D Thakkar, ... Journal for immunotherapy of cancer 9 (3), 2021 | 85 | 2021 |
| Lymphocytic choriomeningitis virus persistence promotes effector-like memory differentiation and enhances mucosal T cell distribution LK Beura, KG Anderson, JM Schenkel, JJ Locquiao, KA Fraser, V Vezys, ... Journal of Leucocyte Biology 97 (2), 217-225, 2015 | 57 | 2015 |
| A Fas-4-1BB fusion protein converts a death to a pro-survival signal and enhances T cell therapy SK Oda, KG Anderson, P Ravikumar, P Bonson, NM Garcia, CM Jenkins, ... Journal of Experimental Medicine 217 (12), e20191166, 2020 | 53 | 2020 |
| ISB-Swedish COVID-19 Biobanking Unit. Multiple early factors anticipate post-acute COVID-19 sequelae Y Su, D Yuan, DG Chen, RH Ng, K Wang, J Choi, S Li, S Hong, R Zhang, ... Cell 185 (5), 881-895, 2022 | 47 | 2022 |
| CpG-mediated modulation of MDSC contributes to the efficacy of Ad5-TRAIL therapy against renal cell carcinoma BR James, KG Anderson, EL Brincks, TA Kucaba, LA Norian, D Masopust, ... Cancer Immunology, Immunotherapy 63, 1213-1227, 2014 | 40 | 2014 |
| Engineered adoptive T-cell therapy prolongs survival in a preclinical model of advanced-stage ovarian cancer KG Anderson, V Voillet, BM Bates, EY Chiu, MG Burnett, NM Garcia, ... Cancer immunology research 7 (9), 1412-1425, 2019 | 31 | 2019 |
| Shortened intervals during heterologous boosting preserve memory CD8 T cell function but compromise longevity EA Thompson, LK Beura, CE Nelson, KG Anderson, V Vezys The Journal of Immunology 196 (7), 3054-3063, 2016 | 27 | 2016 |
| Pulmonary resident memory CD8 T cells: here today, gone tomorrow KG Anderson, D Masopust Journal of leukocyte biology 95 (2), 199-201, 2014 | 18 | 2014 |
| Engineering adoptive T cell therapy to co-opt Fas ligand-mediated death signaling in ovarian cancer enhances therapeutic efficacy KG Anderson, SK Oda, BM Bates, MG Burnett, MR Suarez, SL Ruskin, ... Journal for ImmunoTherapy of Cancer 10 (3), 2022 | 12 | 2022 |
| Development of a clinically relevant ovarian cancer model incorporating surgical cytoreduction to evaluate treatment of micro-metastatic disease CB Morse, V Voillet, BM Bates, EY Chiu, NM Garcia, R Gottardo, ... Gynecologic oncology 160 (2), 427-437, 2021 | 8 | 2021 |
| Leveraging immune resistance archetypes in solid cancer to inform next-generation anticancer therapies KG Anderson, DA Braun, A Buqué, SB Gitto, JL Guerriero, B Horton, ... Journal for immunotherapy of cancer 11 (6), 2023 | 5 | 2023 |
| Cheating death: a Fas-41BB immunomodulatory fusion protein obviates a death signal to enhance T cell function and adoptive therapy targeting leukemia and solid tumors SK Oda, KG Anderson, N Garcia, P Ravikumar, A Daman, P Bonson, ... The Journal of Immunology 200 (1_Supplement), 179.11-179.11, 2018 | 3 | 2018 |
| Heterogeneous immunological recovery trajectories revealed in post-acute COVID-19 Y Su, D Yuan, DG Chen, K Wang, J Choi, CL Dai, S Hong, R Zhang, J Xie, ... medRxiv, 2021.03. 19.21254004, 2021 | 2 | 2021 |
| 561 Triple checkpoint blockade, but not anti-PD1 alone, enhances the efficacy of engineered adoptive T cell therapy in advanced ovarian cancer K Anderson, Y Su, M Burnett, B Bates, MR Suarez, S Ruskin, A Vakil, ... J Immunother 9 (2), A1-A1052, 2021 | 1 | 2021 |
